Literature DB >> 18784104

Recent advances in head and neck cancer.

Robert I Haddad1, Dong M Shin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18784104     DOI: 10.1056/NEJMra0707975

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  329 in total

Review 1.  Chemopreventive potential of natural compounds in head and neck cancer.

Authors:  Mohammad Aminur Rahman; A R M Ruhul Amin; Dong M Shin
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

Review 2.  Biomarkers predicting malignant progression of laryngeal epithelial precursor lesions: a systematic review.

Authors:  Juan P Rodrigo; Juana María García-Pedrero; Carlos Suárez; Robert P Takes; Lester D R Thompson; Pieter J Slootweg; Julia A Woolgar; William H Westra; Ruud H Brakenhoff; Alessandra Rinaldo; Kenneth O Devaney; Michelle D Williams; Douglas R Gnepp; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-12       Impact factor: 2.503

Review 3.  Perineural invasion and associated pain in pancreatic cancer.

Authors:  Aditi A Bapat; Galen Hostetter; Daniel D Von Hoff; Haiyong Han
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

4.  Mandibular reconstruction using free bone flap after preoperative chemoradiation.

Authors:  Heikki Irjala; Ilpo Kinnunen; Kalle Aitasalo
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-10-12       Impact factor: 2.503

5.  Combination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo.

Authors:  Yuan Zhao; Yubin Hao; Hongguang Ji; Yayin Fang; Yinhan Guo; Wei Sha; Yanfei Zhou; Xiaowu Pang; William M Southerland; Joseph A Califano; Xinbin Gu
Journal:  Cancer Prev Res (Phila)       Date:  2010-05-25

6.  Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines.

Authors:  Eric Luedke; Alena Cristina Jaime-Ramirez; Neela Bhave; Julie Roda; Moaz Maqbool Choudhary; Bhavna Kumar; Theodoros N Teknos; William E Carson
Journal:  Surgery       Date:  2012-07-06       Impact factor: 3.982

Review 7.  Immune Evasion by Head and Neck Cancer: Foundations for Combination Therapy.

Authors:  Joshua D Horton; Hannah M Knochelmann; Terry A Day; Chrystal M Paulos; David M Neskey
Journal:  Trends Cancer       Date:  2019-03-20

8.  Overexpression of DDR2 contributes to cell invasion and migration in head and neck squamous cell carcinoma.

Authors:  Jinke Xu; Wei Lu; Senlin Zhang; Chuchao Zhu; Tingting Ren; Tong Zhu; Hu Zhao; Yanpu Liu; Jin Su
Journal:  Cancer Biol Ther       Date:  2014-02-20       Impact factor: 4.742

Review 9.  Interaction of antibodies with ErbB receptor extracellular regions.

Authors:  Karl R Schmitz; Kathryn M Ferguson
Journal:  Exp Cell Res       Date:  2008-10-22       Impact factor: 3.905

10.  A DNA methyltransferase inhibitor and all-trans retinoic acid reduce oral cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide.

Authors:  Xiao-Han Tang; Martin Albert; Theresa Scognamiglio; Lorraine J Gudas
Journal:  Cancer Prev Res (Phila)       Date:  2009-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.